Denali Therapeutics Inc.
DNLI
$15.15
$0.261.75%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 832.33M | 836.56M | 896.04M | 936.87M | 1.03B |
| Total Receivables | 2.17M | 1.40M | 1.40M | 1.90M | 3.42M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 29.93M | 30.88M | 30.94M | 34.81M | 26.21M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 864.44M | 868.84M | 928.38M | 973.58M | 1.06B |
|
|
|||||
| Total Current Assets | 864.44M | 868.84M | 928.38M | 973.58M | 1.06B |
| Net Property, Plant & Equipment | 125.63M | 113.22M | 72.61M | 72.17M | 71.64M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 9.74M | 26.49M | 50.58M | 44.62M | 18.14M |
| Total Assets | 1.37B | 1.45B | 1.50B | 1.58B | 1.15B |
|
|
|||||
| Total Accounts Payable | 11.14M | 9.59M | 13.94M | 11.86M | 9.48M |
| Total Accrued Expenses | 64.91M | 53.14M | 42.59M | 50.72M | 61.24M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.03M | 8.09M | 7.77M | 7.51M | 7.26M |
| Total Finance Division Other Current Liabilities | 14.13M | 16.27M | 10.23M | 12.50M | -- |
| Total Other Current Liabilities | 14.13M | 16.27M | 10.23M | 12.50M | -- |
| Total Current Liabilities | 102.21M | 87.09M | 74.53M | 82.58M | 77.98M |
|
|
|||||
| Total Current Liabilities | 102.21M | 87.09M | 74.53M | 82.58M | 77.98M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 42.29M | 44.48M | 40.98M | 43.03M | 44.98M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 3.94M | -- | -- | -- |
| Total Liabilities | 144.50M | 135.52M | 115.51M | 125.62M | 122.96M |
|
|
|||||
| Common Stock & APIC | 2.77B | 2.74B | 2.71B | 2.67B | 2.15B |
| Retained Earnings | -1.54B | -1.42B | -1.32B | -1.22B | -1.12B |
| Treasury Stock & Other | 2.02M | 5.53M | -2.66M | -1.30M | 643.00K |
| Total Common Equity | 1.23B | 1.32B | 1.39B | 1.46B | 1.03B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.23B | 1.32B | 1.39B | 1.46B | 1.03B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.23B | 1.32B | 1.39B | 1.46B | 1.03B |
|
|
|||||
